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Highly water soluble room temperature superionic liquids of APIs  
Gonçalo V. S. M. Carrera,a,†, Miguel M. Santos,a,† Alexandra Costa,a Luis Paulo N. Rebelo,a Isabel 
M. Marrucho,b,c M. Nunes da Ponte,a Luis C. Brancoa,*
Herein a straightforward approach for the enhancement of water 
solubility of common antibiotic and NSAID Active Pharmaceutical 
Ingredients (APIs) is presented. The APIs are converted into Ionic 
Liquids (API-ILs) and molten salts by combination with the organic 
superbases TMG, DBU and DBN. The prepared superionic liquids 
were characterized by 1H and 13C NMR as well as FTIR 
spectroscopy and elemental analysis. Most products are 
amorphous non-polymorphic Room Temperature Ionic Liquids 
with very high solubility in water, which may enhance the 
bioavailability of the API-ILs in comparison with the parent drugs. 
 
The virtually infinite possibility of cation and anion 
combinations in Ionic Liquids (ILs)1 makes them a class of 
compounds with fine-tunable physicochemical properties as 
well as biological and pharmaceutical activities which allows 
their use over a broad range of fields. Protic ionic liquids (PILs) 
are obtained by an acid-base reaction between a proton donor 
and an acceptor that establish very stable hydrogen bond 
interactions.2 An appropriate choice of acids and bases can 
lead to the formation of task specific PILs, for instance in 
organic synthesis, fuel cells, explosives as well as analytical and 
biological applications.3,4 Such compounds are considered 
ionic if the acid and base (conjugated acid) species possess a 
pKa difference higher than 4.5  This is particularly attainable 
with organic superbases, which generally display pKa values 
higher than 10, as they easily protonate other molecules and 
establish very stable anion-cation interactions. Infact, the so-
called superionic liquids have been studied for biomass 
processing, CO2/SO2 capture and catalysis.4  
Nowadays, the pharmaceutical industry faces a series of 
challenges related with the methodologies used in the 
discovery of new effective drugs. The convenient manipulation 
of solid APIs in order to ease the formulation of the drugs 
walks alongside with many disadvantages such as polymorphic 
conversion, low bioavailability associated with crystalline 
solids, and the tendency of amorphous forms to spontaneously 
crystallize. For these reasons, and due to legal conflicts related 
with different polymorphs, the use of an active drug in liquid 
form can be a reliable solution.6,7 The bioavailability of 
pharmaceutical drugs depends critically on their water 
solubility. Many phase II trials of new prospective Active 
Pharmaceutical Ingredients (APIs) fail because of their poor 
solubility in water and biological fluids.6,8  The most common 
strategy used by the pharmaceutical industry in order to 
increase bioavailability is still to transform the API into a salt, 
usually by combining it with sodium or potassium. Recently, 
the use of APIs as Ionic Liquids (API-ILs) as an alternative has 
been investigated by the academy.7 The works involving the 
preparation of API-ILs from ampicillin,9,10 fluoroquinolones,11 
ibuprofen,7 ranitidine7 and lidocaine,7 and also acetylsalicylic 
and salicylic acids,12 among others,13  have shown that the 
combination of an API, either as a cation or as an anion, with a 
suitable biocompatible counter-ion can increase the water 
solubility of the parent drug and even change its biological 
effect.14,15 In face of these results it is suggested that the oral 
bioavailability of the formed API-ILs is particularly enhanced, 
or alternatively it may open new perspectives for their local 
administration/application. Therefore, the therapeutic dosage 
of the drug may be reduced, thereby decreasing side effects. 
Herein, a new efficient methodology for the preparation of 
API-ILs is presented and discussed. It transforms poorly water 
soluble, neutral APIs bearing one carboxylic acid appendage 
into highly water soluble ILs or molten salts by combination 





Figure 1. Preparation of protic API-ILs by direct protonation of superbases.  
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The three superbases 1,1,3,3-tetramethylguanidine (TMG), 
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and 1,5-
diazabicyclo(4.3.0)non-5-ene (DBN) were coupled with several 
antibiotic and NSAID APIs. In the antibiotic family, ampicillin 
(AMP), ciprofloxacin (CIP) and norfloxacin (NOR) were used, as 
well as 6-aminopenicellanic acid (APA), which is a synthetic 
intermediate in the synthesis of penicillin derivatives. The 
chosen NSAIDs were ibuprofen (IBU) and naproxen (NPX). The 
structure of the 17 new ionic liquids and molten salts is 
displayed in Figure 2. 
Bearing in mind the potential pharmaceutical application of 
these ionic liquids, we would like to stress that in general 
protic ILs are usually less toxic than the aprotic ones.16-21  
All prepared salts were obtained in high yield (89 to 100%) and 
purity levels using a sustainable synthetic methodology which 
guarantees an atom economy process. All novel API ionic 
liquids or salts were completely characterized by spectroscopic 
techniques, namely 1H and 13C NMR and FTIR, and elemental 
analysis. Additionally, the thermal properties of the final 
products were evaluated by calorimetric studies (DSC analysis) 
and their solubility in water was also determined. 
Table 1 summarizes relevant 13C NMR and FTIR spectroscopic 
data of the novel TMG-, DBU- and DBN-based salts and parent 
APIs. It is possible to conclude by 1H and 13C NMR data that all 
reactions reached completion (only one set of signals was 
observed in every spectrum). In the case of [TMGH]-based 
compounds, the protonation of TMG induces a significant 
shielding increase of the guanidinium quaternary carbon atom 
which is expressed by a characteristic upfield deviation of the 
13C NMR resonance of this atom.22 More precisely, the given 
signal varies ca. 5 ppm from δ 167.8 ppm for the neutral TMG 
in CDCl3 up to δ values between 162.8 – 162.1 ppm for the 
TMG based salts of [NPX], [IBU], [APA] and [AMP] (Table 1). 
For [CIP]- and [NOR]-based salts, the corresponding upfield 
variation was 5.9 and 2.3 ppm in CD3OD and DMSO-d6, 
respectively. On the other hand, for the [DBUH]- and [DBNH]-
based salts the variation of the 13C NMR resonance of the 
quaternary carbon C=N+ occurs downfield as reported,23 
reflecting the weaker shielding of the protonated amidine core. 
When the spectra are collected in CDCl3, the observed 
variation is ca. 4.5 ppm for both groups of PILs, but increases 













Figure 2. Molecular structure of the APIs and superbases (SB) used. 
Table 1. 13C NMR and FTIR data of the prepared salts, superbases (SB) and APIs 
Cation Anion 
13C NMR δ /ppm FTIR ν /cm-1 
C=N C=N C=O 













CIP 163.3a 169.2a 1629 1575 1589 
















AMP 166.3 1649 1603 1598 
CIP 167.5a 164.2a 1648 1583 1589 
NOR 167.3b 159.7b 1650 1584 1583 
IBU 166.0 
161.5 
1648 1589 1721 








AMP 165.9a 1680 1602 1598 
CIP 165.8a 1680 1586 1589 
NOR 165.8a 1680 1584 1583 
IBU 164.1 160.5 1681 1565 1721 
CDCl3 was the solvent for all 13C NMR spectra except a) CD3OD and b) DMSO-d6. 
Additionally, the 13C NMR resonance of the quaternary carbon 
atom of the anion’s carboxylate group is, as expected, 
deviated from the corresponding group in the parent APIs. This 
variation is more discrete, ca. 1 ppm, than the ones reported 
for the quaternary carbon atom of the guanidinium and 
amidinium cations, and is in agreement with the stabilized 
resonance structure of the carboxylate groups. This 
comparison can only be performed for the [NPX]-, [IBU]- and 
[AMP]-based salts as the remaining parent APIs were not 
soluble in the same deuterated solvents. 
The formation of the desired salts is also supported by FTIR 
data (Table 1). On one hand, all spectra showed a medium to 
high intensity band between 1606 and 1565 cm-1 which is 
consistent with the characteristic vibration of the CO2- group of 
the anionic APIs. This is particularly manifest for the salts 
containing [IBU] and [NPX] because the carboxylic acid group 
of the parent APIs is completely protonated before 
combination with the superbases, according to their non-
zwitterionic nature. On the other hand, the formation of the 
salts can also be evaluated by changes in the vibration modes 
of the superbases’ C-N bonds. In the neat state, both TMG and 
DBN exhibit two vibrational modes between 1700-1600 cm-1 of 
similar intensity, more precisely 1651 (νT1) and 1616 (νT2) cm-1 
for the former and 1681 (νD1) and 1645 (νD2) cm-1 for the latter. 
Upon combination with [APA], [AMP], [IBU] and [NPX], the 
FTIR spectra of [TMGH]-based salts show that νT2 becomes the 
most intense band, with a slight deviation to lower 
wavenumbers (1609-1605 cm-1), while νT1 remains practically 
unchanged. In the case of the [TMGH][CIP] and [TMGH][NOR] 
salts, νT1 and νT2 appear superimposed with the very strong 
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band corresponding to N-H stretching from the amines of the 
anion at 1629 cm-1. In contrast, the FTIR spectrum of the 
[DBNH]-based salts show the vibrational mode νD1 with minor 
variations in wavelength. Finally, the N-H stretching vibration 
of DBU at 1650 cm-1 remains practically unaltered upon 
combination with the corresponding APIs. 
Considering the data presented in Table 1, it is possible to 
observe that the variation between the wavenumber values 
for the asymmetrical stretch of the carboxylate and carboxylic 
acid groups of the starting APIs and the final compounds is 
higher for the [TMGH]-based salts than for the ones with the 
other organic superbases. This observation is in complete 
agreement with a more stable interaction between the APIs 
and TMG than with the other superbases, given its highest pKa 
value (13.6) in comparison with DBU (11.5) and DBN (12.7). 
Taking into account the structures of the carboxylate and the 
guanidine groups, we suggest that the cation-anion interaction 
takes place through a hexagonal structure stabilized by 
hydrogen bonds as depicted in Figure 3. 
Table 2 contains the collected data from the calorimetric (DSC) 
studies. All salts containing [APA] and [AMP], as well as 
[DBNH][NOR], [DBUH][IBU], [DBNH][IBU] and [DBUH][NPX] are 
orange, yellow or colorless pastes, thus are considered Room 
Temperature Ionic Liquids. The melting temperature of these 
RTILs was not observed through Differential Scanning 
Calorimetry (DSC) studies conducted between -90 °C and     
150 °C, although some presented glass transition temperatures 
(Tg) consistent with amorphous structures. Figure 4 contains 
the DSC data of three of the prepared RTILs, more specifically 
[DBNH][NOR], [DBUH][IBU] and [DBUH][NPX], which are 
extremely soluble in water (vide infra). The remaining salts are 
solids that melt at temperatures higher than 148 °C except for 
[TMGH][IBU]. The observed physical state of these compounds 
is in agreement with the strength of the anion-cation 
interactions described above. In other words, once TMG tends 
to yield more stable associations with the APIs, there is a 
higher tendency of these ionic compounds to possess higher 
melting points than the ones with the remaining superbases, 
which establish weaker interactions given the ΔpKa between 
the SBs and APIs. Finally, none of the prepared RTILs and salts 
present polymorphic structures, contrarily to the parent 
APIs.26-30 
It is worth mentioning that the prepared RTILs show a very 
significant increase of solubility in water in comparison with the 
parent APIs as opposed to the solid salts (see Figure 5). In 
addition, [DBNH] seems to be the best cation in terms of water 
solubility with three out of five APIs. In fact, the most striking 
results were recorded for [DBNH][NOR] and [DBNH][IBU], as well as 






Figure 3. Six-membered ring structure stabilized by hydrogen bonds between a generic 
carboxylic acid moiety from an API and the guanidine from TMG. 
Table 2. Physical state, melting and glass transition temperatures of the salts and APIs. 





TMGH Orange paste liq. 
199 
6.6 
DBUH Orange paste liq. 83.8 
DBNH Orange paste liq. 78.7 
AMP 
TMGH White paste liq. 
208 
114.6 
DBUH White paste liq. 105.1 
DBNH Yellow paste liq. 115.3 
CIP 
TMGH White solid > 200 
256 
– 
DBUH White solid > 200 – 
DBNH White solid 160 dec. 66.4 
NOR 
TMGH White solid > 200 
227 
– 
DBUH Yellow solid 160 – 
DBNH Yellow paste liq. -0.4 
IBU 
TMGH White solid 115.4* 
76 
-11.8 
DBUH Colorless paste liq. -12.0 
DBNH Colorless liquid liq. -21.4 
NPX 
TMGH Yellow solid 149 
153 
– 
DBUH Yellow paste liq. 20.1 
a Melting temperature (Tm) of the salts was determined using a melting point 
apparatus *except for [TMGH][IBU], which was determined by DSC 
measurements. b Glass transition temperature (Tg) was determined by DSC 
measurements at a heating/cooling rate of 10 °C min-1. c Tm of APIs from 
references APA24, AMP25, CIP24, NOR25, IBU25, NPX25. 
From these three RTILs, the first and last ones are particularly 
relevant because the remaining [NOR] and [NPX] based salts 
were found to be insoluble in the tested concentrations (c < 6 
mg.mL-1). On the other hand, the [TMGH] and [DBUH] salts of 
[IBU] recorded, respectively, 35500- and 63500-fold increase in 
water solubility in comparison with the parent drug. 
[DBNH][APA] was also the most water soluble salt of the [APA] 
family, with over 1000-fold increase comparing to the parent 
API. Similarly to NPX, it was the salt of [AMP] with [DBUH] that 
showed the highest value of water solubility. Finally, none of 
the [CIP] salts showed relevant water solubility. 
Thus, through combination with the organic superbases TMG, 
DBU and DBN, we could, in a sustainable fashion, transform 
polymorphic APIs – AMP, NOR, IBU and NPX – or synthetic 
precursors (e.g. APA), into non-polymorphic amorphous Room  
 
 
Figure 4. Pictures of [DBNH][NOR], [DBUH][IBU] and [DBUH][NPX] (from top to 
bottom), and corresponding DSC data. 
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Figure 5. Plot of water solubility of the APIs and synthesized ILs. Water solubility of APIs 
from references APA,31 AMP,32 CIP,33 NOR,33 IBU,25 NPX.25 The high and low thresholds 
are respectively the highest and lowest concentrations in water of the API-ILs. 
Temperature Ionic Liquids or salts which, in the vast majority of 
cases, display extremely high solubility in water. These 
properties significantly affect the bioavailability of the APIs, as 
well as possibly their pharmaceutical effect. Future biological, 
toxicological and pharmaceutical studies will be performed 
soon with selected protic ILs and reported elsewhere. 
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